Inicio › Mieloma múltiple › Nebraska › Omaha
Ensayos clínicos de Mieloma múltiple en Omaha, NE
16 estudios para Mieloma múltiple buscan participantes en centros de Omaha y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 3
- Nebraska Cancer Specialists, Omaha
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutandoFase 3
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- University of Nebraska Medical Center, Omaha
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
ReclutandoFase 1/2
- Nebraska Cancer Institute, Omaha
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Reclutando
- University of Nebraska Medical Center, Omaha
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ReclutandoFase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
ReclutandoFase 1
- University of Nebraska, Omaha
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ReclutandoFase 2
- University of Nebraska Medical Center, Omaha
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
Reclutando
- Unversity of Nebraska Medical Center, Omaha
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
ReclutandoFase 1
- University Of Nebraska Medical Center, Omaha
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Halt Aging in Survivors of Blood Cancers
Reclutando
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- y 1 más
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
ReclutandoFase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ReclutandoFase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- y 1 más
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
ReclutandoFase 2
- Nebraska Cancer Specialists, Omaha
Más información sobre Mieloma múltiple en MedlinePlus
Ensayos de Mieloma múltiple en otras ciudades
- New York City, NY60 estudios
- Boston, MA42 estudios
- Atlanta, GA41 estudios
- Houston, TX38 estudios
- Durham, NC37 estudios
- Nashville, TN32 estudios
- Denver, CO27 estudios
- Rochester, MN24 estudios
- St. Louis, MO24 estudios
- Columbus, OH24 estudios
- Baldwin Park, CA23 estudios
- Chicago, IL22 estudios
Otros estudios en Omaha
- Cáncer de próstata27 estudios
- Cáncer de pulmón de células no pequeñas24 estudios
- Cáncer de seno22 estudios
- Cáncer del colon y del recto18 estudios
- Cáncer (todos los tipos)18 estudios
- Linfoma no Hodgkin14 estudios
- Cáncer de ovario14 estudios
- Cáncer de páncreas14 estudios
- Carcinoma de células escamosas de cabeza y cuello13 estudios
- Fallo cardíaco13 estudios
- Cáncer metastásico13 estudios
- Cáncer de riñón (carcinoma de células renales)12 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.